Inogen Inc
NASDAQ:INGN

Watchlist Manager
Inogen Inc Logo
Inogen Inc
NASDAQ:INGN
Watchlist
Price: 8.565 USD 1.6% Market Closed
Market Cap: 204m USD
Have any thoughts about
Inogen Inc?
Write Note

Inogen Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Inogen Inc
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Inogen Inc
NASDAQ:INGN
Accrued Liabilities
$21.4m
CAGR 3-Years
4%
CAGR 5-Years
12%
CAGR 10-Years
19%
Becton Dickinson and Co
NYSE:BDX
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Accrued Liabilities
$2.3B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Accrued Liabilities
$3.5B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
3%
Abbott Laboratories
NYSE:ABT
Accrued Liabilities
$7B
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Accrued Liabilities
$867.5m
CAGR 3-Years
21%
CAGR 5-Years
13%
CAGR 10-Years
15%
No Stocks Found

Inogen Inc
Glance View

Market Cap
204m USD
Industry
Health Care

Inogen, Inc. engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 1,021 full-time employees. The company went IPO on 2014-02-14. The firm primarily develops, manufactures, and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen with a single battery and can be plugged into a power outlet as needed. All of its Inogen One systems are equipped with Intelligent Delivery Technology, a form of pulse-dose technology, from which the patient receives a bolus of oxygen upon inhalation. The company has also launched Inogen Connect, a wireless connectivity platform for the Inogen One G4 and Inogen One G5 (portable oxygen concentrators) consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers.

INGN Intrinsic Value
13.603 USD
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Inogen Inc's Accrued Liabilities?
Accrued Liabilities
21.4m USD

Based on the financial report for Sep 30, 2024, Inogen Inc's Accrued Liabilities amounts to 21.4m USD.

What is Inogen Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
19%

Over the last year, the Accrued Liabilities growth was 22%. The average annual Accrued Liabilities growth rates for Inogen Inc have been 4% over the past three years , 12% over the past five years , and 19% over the past ten years .

Back to Top